Skip to content
★ Sign in to follow
EW
Total declarations
16
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 08 May 2025 for GSK plc.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

E Walmsley: trading record in brief

E Walmsley appears in our data through filings on GSK plc shares, published by RNS (LSE). We count 16 filings; the first trade dates from 27 July 2022 and the latest from 7 May 2025.

Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 8 May 2025, the filings show a share grant in GSK plc. Between a trade and the moment it shows up on RNS (LSE), the median delay is 2 days. The regulation allows three business days to notify a trade (UK MAR). Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to E Walmsley

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total
  • ◆
    Chief Executive OfficerExecutivesGSK plc
    0RNS
    149,560 sharesN/AISIN GB00BN7SWP63RNS:5647100
  • ◆
    Chief Executive OfficerExecutivesGSK plc
    35,511 GBP30RNS
    2,670 shares@ £13.3097.8% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4842360-0
  • ◆
    Chief Executive OfficerExecutivesGSK plc
    0RNS
    0London Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4842360-13
  • ◆
    Chief Executive OfficerExecutivesGSK plc
    0RNS
    0London Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4842360-12
  • ◆
    Chief Executive OfficerExecutivesGSK plc
    320 GBP40RNS
    24 shares@ £13.35290.9% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4837969-0
  • ◆
    Chief Executive OfficerExecutivesGSK plc
    235 GBP40RNS
    18 shares@ £13.06720.7% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4835002-0
  • ◆
    Chief Executive OfficerExecutivesGSK plc
    248 GBP40RNS
    18 shares@ £13.79670.7% of flowLondon Stock Exchange (XLON)ISIN GB00BN7SWP63RNS:4799763-0
  • ◆
    Chief Executive OfficerExecutivesGSK plc
    29,679 GBP0FCA-NSM
    2,244 shares@ £13.226London Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4543614-0
  • ◆
    Chief Executive OfficerExecutivesGSK plc
    60,239 GBP0FCA-NSM
    4,438.508 shares@ £13.5718London Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4543310-0
  • ◆
    Chief Executive OfficerExecutivesGSK plc
    271 GBP0FCA-NSM
    20 shares@ £13.554London Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4543181-0
  • ◆
    Chief Executive OfficerExecutivesGSK plc
    105,320 GBP0FCA-NSM
    7,963.086 shares@ £13.226London Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4541930-0
  • ◆
    Chief Executive OfficerExecutivesGSK plc
    333 GBP0FCA-NSM
    25 shares@ £13.3392London Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4537632-0
  • ◆
    Chief Executive OfficerExecutivesGSK plc
    245 GBP0FCA-NSM
    18 shares@ £13.6211London Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4507899-0
  • ◆
    Chief Executive OfficerExecutivesGSK plc
    263 GBP0FCA-NSM
    16 shares@ £16.4131London Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4471508-0
  • ◆
    Chief Executive OfficerExecutivesGSK plc
    0FCA-NSM
    307,823.304 sharesN/AISIN GB00BN7SWP63FCA-NSM:4458353-0
  • ◆
    Chief Executive OfficerExecutivesGSK plc
    0FCA-NSM
    148,525 sharesLondon Stock Exchange (XLON)ISIN GB00BN7SWP63FCA-NSM:4458353-1

16 of 16 declarations